You are here
P&T October 2013
Features
State policies vary regarding the legal use of marijuana for medicinal purposes. Pharmacists, physicians, and P&T committee members must become familiar with the laws in their states before assuming that this controlled substance can be legally prescribed or dispensed to patients.
Many obstacles currently limit the ability to apply our knowledge of gene–drug associations in pharmacy practice. However, steps are gradually being taken toward the goal of incorporating genetic testing into routine patient care.
Respondents generally rated their experiences with consultants as positive. However, participants’ responses varied in terms of how much they felt that the consultants were helping their organizations to cut costs and increase revenue.
Departments
FDA approvals, drug indications, and updates
Dolutegravir (Tivicay) for HIV-1 infection; topiramate extended release (Trokendi XR) for epilepsy; and ferric carboxymaltose (Injectafer) for iron-deficiency anemia